Skip to main content
Nath Biogene India Ltd. logo

Nath Biogene India Ltd. — Investor Relations & Filings

Ticker · NATHBIOGEN ISIN · INE448G01010 BSE.NS Agriculture, forestry and fishing
Open in API
Filings indexed 449 across all filing types
Latest filing 2026-05-11 Call Transcript
Country IN India
Listing BSE.NS NATHBIOGEN

About Nath Biogene India Ltd.

https://www.nathbiogenes.com

Nath Biogene India Ltd. specializes in the research, development, production, and marketing of high-quality hybrid seeds. The company maintains a diverse product portfolio encompassing field crops such as cotton, paddy, maize, jowar, and bajra, alongside a wide range of vegetable seeds including tomato, okra, and chili. With a strong emphasis on biotechnological innovation and plant breeding, the organization focuses on developing high-yielding, pest-resistant, and climate-resilient seed varieties to enhance agricultural productivity. Its operations are supported by extensive research and development facilities and a robust distribution network that ensures the delivery of advanced genetic materials to farming communities. The company leverages its technical expertise to provide integrated solutions aimed at improving crop quality and farmer profitability through sustainable agricultural practices.

Recent filings

Filing Released Lang Actions
General Updates
Call Transcript Classification · 95% confidence The document contains the full transcript of Nath Bio-Genes Limited’s Q4 FY26 earnings conference call (with moderator instructions, management presentations, and Q&A). It is not merely an announcement but the substantive call transcript itself. Therefore, it should be classified as a Call Transcript.
2026-05-11 English
General Updates
Regulatory Filings Classification · 92% confidence The document is a compliance announcement under SEBI Listing Regulations informing stock exchanges that the audio recording of the earnings conference call is now available via a website link. It does not contain financial data, a transcript, or substantive report content itself, but is a regulatory disclosure to the exchange under Reg 30. This fits the catch-all “Regulatory Filings” category for miscellaneous compliance announcements.
2026-05-11 English
Earning Call Transcript held on 05th May 2026
Call Transcript Classification · 92% confidence The document is a complete transcript of the Q4 FY26 earnings conference call, including a moderator introduction, management presentations, and a detailed Q&A session. It is not a summary earnings release but the verbatim call transcript provided to investors and analysts. Therefore, it should be classified as a Call Transcript.
2026-05-11 English
Audio Transcript of Concall held on 05th May 2026.
Regulatory Filings Classification · 85% confidence The document is a brief compliance announcement under SEBI LODR Regulation 30 notifying stock exchanges that the audio recording of a conference call is available on the company’s website. It does not contain substantive financial data, nor is it the conference call transcript itself. It is an official regulatory announcement, so it falls into the general Regulatory Filings category (RNS).
2026-05-11 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings Classification · 20% confidence The document is a compliance confirmation letter addressed to stock exchanges under SEBI circular SEBI/HO/DDHS/CIR/P/2018/144, stating that the company is not classified as a large corporate as of 31 March 2026. It contains no financial statements, no management discussion, no corporate action announcement other than regulatory compliance. It is an officer certification/compliance submission rather than a financial report or specific corporate action. Therefore, it falls under Regulatory Filings (RNS).
2026-05-11 English
General Updates
Investor Presentation Classification · 95% confidence The document is titled as an "Investor Presentation Q4 & FY26" and contains detailed financial highlights, business strategy, segmental revenue, income statement, balance sheet, and testimonials. It is explicitly described as a presentation on audited financial results for the period ended 31st March 2026. The content includes forward-looking statements, business overview, financial performance, and leadership information, typical of an investor presentation. The document length is over 13,000 characters, indicating it is a full presentation rather than a brief announcement. There is no indication that this is a full annual report (10-K) or an interim/quarterly report (IR) with full financial statements in regulatory format. It is clearly a presentation aimed at investors summarizing financial results and business highlights. Therefore, the most appropriate classification is Investor Presentation (IP).
2026-05-04 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.